Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 9, 2007, Pages 4079-4086

  Ito, Yasuki ^a   Nakamura, Makoto ^a   Yamakoshi, Tomomi ^a   Lin, Jian ^a   Yatsuya, Hiroshi ^a   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; HUMAN; MALE; MORPHOLOGY; NERVE FIBER; OPA1 GENE; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA BIPOLAR GANGLION CELL; RETINA FOVEA; RETINA MACULA LUTEA; RETINA NERVE CELL; VISUAL ACUITY; AGED; GENETICS; MIDDLE AGED; MORPHOMETRICS; MUTATION; PATHOLOGY; RETINA GANGLION CELL;

GUANOSINE TRIPHOSPHATASE; OPA1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED, 80 AND OVER; BODY WEIGHTS AND MEASURES; FEMALE; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE FIBERS; OPTIC ATROPHY, AUTOSOMAL DOMINANT; PHOTORECEPTORS, VERTEBRATE; RETINA; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 35148886673     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0024     Document Type: Article

References (46)

1. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Scand. 1959;37(suppl 54):1-146.
2. Lyle WM. Genetic Risks. Waterloo, Ontario, Canada: University of Waterloo Press; 1990.
3. Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74:3-7.
4. Kline LB, Glaser JS. Dominant optic atrophy; the clinical profile. Arch Ophthalmol. 1979;97:1680-1686.
5. Hoyt CS. Autosomal dominant optic atrophy: a spectrum of disability. Ophthalmology. 1980;87:245-251.
6. Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab. 2002;75:97-107.
7. Votruba M, Moore AT, Bhattacharya SS. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet. 1998;35:793-800.
8. Patel N, Churchill AJ, Toomes C, et al. Importance of molecular testing in dominant optic atrophy. Br J Ophthalmol. 2002;86:1314-1315.
9. Johnston PB, Gaster RN, Smith VC, Tripathi RC. A clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol. 1979;88:868-875.
10. Johnston RL, Seller MJ, Behnam JT, Burdon MA, Spalton DJ. Dominant optic atrophy: refining the clinical diagnostic criteria in light of genetic linkage studies. Ophthalmology. 1999;106:123-128.
11. Brown J Jr, Fingert JH, Taylor CM, Lake M, Sheffield VC, Stone EM. Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1). Arch Ophthalmol. 1997;115:95-99.
12. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207-210.
13. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26:211-215.
14. Kerrison JB, Arnould VJ, Ferraz Sallum JM, et al. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol. 1999;117:805-810.
15. Seller MJ, Behnam JT, Lewis CM, Johnston RL, Burdon MA, Spalton DJ. Linkage studies in dominant optic atrophy, Kjer type: possible evidence for heterogeneity. J Med Genet. 1997;34:967-972.
16. Votruba M, Moore AT, Bhattacharya SS. Demonstration of a founder effect and fine mapping of dominant optic atrophy locus on 3q28-qter by linkage disequilibrium method: a study of 38 British Isles pedigrees. Hum Genet. 1998;102:79-86.
17. Delettre C, Griffoin JM, Kaplan J, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet. 2001;109:584-591.
18. Pesch UE, Leo-Kottler B, Mayer S, et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet. 2001;10:1359-1368.
19. Toomes C, Marchbank NJ, Mackey DA, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet. 2001;10:1369-1378.
20. Thiselton DL, Alexander C, Morris A, et al. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Hum Genet. 2001;109:498-502.
21. Shimizu S, Mori N, Kishi M, Sugata H, Tsuda A, Kubota N. A novel mutation of the OPA1 gene in a Japanese family with optic atrophy type 1. Jpn J Ophthalmol. 2002;46:336-340.
22. Thiselton DL, Alexander C, Taanman JW, et al. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci. 2002;43:1715-1724.
23. Shimizu S, Mori N, Kishi M, Sugata H, Tsuda A, Kubota N. A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy. Am J Ophthalmol. 2003;135:256-257.
24. Yamada T, Hayasaka S, Matsumoto M, et al. OPA1 gene mutations in Japanese patients with bilateral optic atrophy unassociated with mitochondrial DNA mutations at nt 11778, 3460, and 14484. Jpn J Ophthalmol. 2003;47:409-411.
25. Baris O, Delettre C, Amati-Bonneau P, et al. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat. 2003;21:656.
26. Namakura M, Lin J, Ueno S, et al. Novel mutations in OPA1 gene and associated clinical features in Japanese patients with optic atrophy. Ophthalmology. 2006;113:483-488.
27. Nakamura M, Miyake Y. Optic atrophy and negative electroretinogram in a patient associated with a novel OPA1 mutation. Graefes Arch Clin Exp Ophthalmol. 2006;244:274-275.
28. Olichon A, Emorine LJ, Descoins E, et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 2002;523:171-176.
29. Yoon Y, McNiven MA. Mitochondrial division: New partners in membrane pinching. Curr Biol. 2001;11:R67-R70.
30. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003;278:7743-7746.
31. Kjer P, Jensen OA, Klinken L. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol (Copenh). 1983;61:300-312.
32. Drexler W, Morgner U, Ghanta RK, Kartner FX, Schuman JS, Fujimoto JG. Ultrahigh-resolution ophthalmic optical coherence tomography. Nat Med. 2001;7:502-507.
33. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol. 2003;21:1361-1367.
34. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121:695-706.
35. Greenfield DS, Bagga H, Knighton RW. Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography. Arch Ophthalmol. 2003;121:41-46.
36. Wollstein G, Schuman JS, Price LL, et al. Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields. Am J Ophthalmol. 2004;138:218-225.
37. Medeiros FA, Zangwill LM, Bowd C, Vessani RM, Susanna R Jr, Weinreb RN. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol. 2005;139:44-55.
38. Barboni P, Savini G, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology. 2005;112:120-126.
39. Kanamori A, Nakamura M, Matsui N, et al. Optical coherence tomography detects characteristic retinal nerve fiber layer thickness corresponding to band atrophy of the optic discs. Ophthalmology. 2004;111:2278-2283.
40. Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol. 2003;135:513-520.
41. Yagasaki K, Miyake Y, Awaya S, Ichikawa H. ERG (electroretinogram) in hereditary optic atrophies (in Japanese). Nippon Ganka Gakkai Zasshi. 1986;90:124-130.
42. Granse L, Bergstrand I, Thiselton D, et al. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene. Ophthalmic Genet. 2003;24:233-245.
43. Miyata K, Nakamura M, Kondo M, et al. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations. Invest Ophthalmol Vis Sci. 2007;48:820-824.
44. Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci. 1997;38:1983-1997.
45. Jacobson SG, Cideciyan AV, Iannaccone A, et al. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:1898-1908.
46. Nakamura M, Lin J, Ito Y, Miyake Y. Novel Mutation in RLBP1 Gene in a Japanese Patient with Retinitis Punctata Albescens. Am J Ophthalmol. 2005;139:1133-1135.